Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Centre for Economic Performance, London School of Economics, London, United Kingdom.
Soc Sci Med. 2018 Aug;211:131-136. doi: 10.1016/j.socscimed.2018.06.009. Epub 2018 Jun 18.
The monetary value of a quality-adjusted life-year (QALY) is frequently used to assess the benefits of health interventions and inform funding decisions. However, there is little consensus on methods for the estimation of this monetary value. In this study, we use life satisfaction as an indicator of 'experienced utility', and estimate the dollar equivalent value of a QALY using a fixed effect model with instrumental variable estimators. Using a nationally-representative longitudinal survey including 28,347 individuals followed during 2002-2015 in Australia, we estimate that individual's willingness to pay for one QALY is approximately A$42,000-A$67,000, and the willingness to pay for not having a long-term condition approximately A$2000 per year. As the estimates are derived using population-level data and a wellbeing measurement of life satisfaction, the approach has the advantage of being socially inclusive and recognizes the significant meaning of people's subjective valuations of health. The method could be particularly useful for nations where QALY thresholds are not yet validated or established.
质量调整生命年(QALY)的货币价值常用于评估健康干预措施的效益并为资金决策提供信息。然而,对于这种货币价值的估算方法,尚未达成共识。在这项研究中,我们使用生活满意度作为“体验效用”的指标,并使用带有工具变量估计量的固定效应模型来估算 QALY 的美元等效价值。我们利用包括 2002 年至 2015 年期间在澳大利亚随访的 28347 名个体的全国代表性纵向调查数据进行研究,结果表明,个体对一个 QALY 的支付意愿约为 42000 澳元至 67000 澳元,对没有长期疾病的支付意愿约为每年 2000 澳元。由于这些估计值是使用人群水平数据和生活满意度的幸福感衡量标准得出的,因此该方法具有社会包容性的优势,并且认识到人们对健康的主观价值的重要意义。对于那些尚未验证或确定 QALY 阈值的国家来说,该方法可能特别有用。